Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Volume Reduction and Process Optimization with Cadence Inline Concentrator
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
View All Featured ArticlesHeadline News
AstraZeneca commits $2 billion to Summit Therapeutics as part of new equity stake and cancer research alliance centered on antibody drug conjugate combinations
FDA approves Teva’s DEGEVMA biosimilar to Xgeva across all reference product indications
EMPAVELI reduces proteinuria and stabilises kidney function in adolescents with C3G or primary IC MPGN
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
The Future of Pharmaceutical Manufacturing: Flexibility and Sustainability through Small Footprint, Modular Equipment Trains
Presented by Daniel O. Blackwood & Jeffrey Moriarty of Pfizer, Inc.
10th October 2017
Using PAT to accelerate and optimize the process development of solid dosage forms.
Presented by Lizbeth Martinez, Ph. D. Associate Director Data Science, Oral Pharmaceutical Development at Novartis Basel Switzerland and Emiliano Genorini, Account Manager – MicroNIR at Viavi Solutions
04th November 2021
Towards Real Time Release testing: Dissolution prediction of tablets made using Continuous Direct Compression
Presented by Pallavi Pawar of GlaxoSmithKline
21st November 2017
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Lifetime study for JSR Amsphere A3 – protein A resin
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
